Shinpoong Pharmaceutical Co (XKRX:019170) Total Equity: ₩278,036 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:019170 Shinpoong Pharmaceutical Co Ltd XKRX:019170
65 GF Score
Price ₩10,070.00
GF Value ₩11,211.69
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Shinpoong Pharmaceutical Co Total Equity?

Shinpoong Pharmaceutical Co XKRX:019170 +0.50% 65 Total Equity is ₩278,036 Mil as of Jun. 2026. GuruFocus rates XKRX:019170 with a GF Score™ of 65/100 and a GF Value™ of ₩11,211.69 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Shinpoong Pharmaceutical Co's total equity for the quarter that ended in Jun. 2026 was ₩278,036 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Shinpoong Pharmaceutical Co Total Equity Historical Data

* Premium members only.

The historical data trend for Shinpoong Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shinpoong Pharmaceutical Co Total Equity Chart

Shinpoong Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 360,324.40 330,758.29 270,782.15 258,089.87 270,727.64

Shinpoong Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 257,327.98 264,200.95 270,727.64 292,260.03 278,035.74
XKRX:019170
65GF Score
Shinpoong Pharmaceutical Co Ltd XKRX:019170
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shinpoong Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Shinpoong Pharmaceutical Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=352466.324-81738.685
=270,728

Shinpoong Pharmaceutical Co's Total Equity for the quarter that ended in Jun. 2026 is calculated as

Total Equity=Total Assets(Q: Jun. 2026 )-Total Liabilities(Q: Jun. 2026 )
=366503.697-88467.961
=278,036

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₩278,036 Mil mean?
Shinpoong Pharmaceutical Co (XKRX:019170) has a Total Equity of ₩278,036 Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Shinpoong Pharmaceutical Co and its competitors.
Is Shinpoong Pharmaceutical Co's Total Equity too high?
Shinpoong Pharmaceutical Co's current Total Equity is ₩278,036 Mil. Overall, Shinpoong Pharmaceutical Co has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shinpoong Pharmaceutical Co's Total Equity compare to ZTS?
Shinpoong Pharmaceutical Co's Total Equity of ₩278,036 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Shinpoong Pharmaceutical Co and its competitors. Shinpoong Pharmaceutical Co's current Total Equity is ₩278,036 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shinpoong Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shinpoong Pharmaceutical Co (XKRX:019170) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩11,211.69, compared to a current price of ₩10,070.00 — trading 10.2% below its estimated fair value. The current Total Equity is ₩278,036 Mil. Shinpoong Pharmaceutical Co's overall GF Score™ is 65/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Shinpoong Pharmaceutical Co (XKRX:019170), the current Total Equity is ₩278,036 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shinpoong Pharmaceutical Co (XKRX:019170) Overvalued in 2026?

Based on GuruFocus' analysis, Shinpoong Pharmaceutical Co stock appears to be undervalued. The current stock price of ₩10,070.00 is trading 10.2% below its estimated GF Value™ of ₩11,211.69. GuruFocus considers Shinpoong Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for XKRX:019170:

  • Total Equity: ₩278,036 Mil
  • GF Value™: ₩11,211.69 vs. price of ₩10,070.00 (10.2% below fair value)
  • GF Score™: 65/100 with 1 warning sign

No single metric tells the full story. See the XKRX:019170 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shinpoong Pharmaceutical Co Business Description

Other Exchanges 019175:Korea
Address 161, Yeoksam-ro, Gangnam-gu, Seoul, KOR, 06246
Shinpoong Pharmaceutical Co Ltd specializes in manufacturing remedy drugs and also active pharmaceutical ingredients and finished products. Its products include Newsicam, Caravenal, Roxagen, Clamoxin duo, Ceroxim, and Clocin. The firm's production facilities are located at Gyeonggi-do and Cheongwon-gun.
65GF Score

Get the complete analysis for XKRX:019170

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩10,070.00
Price
₩11,211.69
GF Value